Spectinomycin inhibits the formation and causes dissociation of preformed specific cellfree initiation complexes prepared with the trinucleotide A-U-G or R,; phage RNA, finet-RNAF and either 30S ribosomal subunits or 70S ribosomes.
This report presents evidence that spectinomycin inhibits the process of peptide chain initiation per se when studied in specific cell-free initiation systems.
Materials and Methods
Salt-washed ribosomes and 30S and 50S ribosomal subunits were prepared as described previously'. E. coli tRNAr•°` was obtained from the Oak Ridge National Laboratories. Synthetase-transformylase enzyme required for the synthesis of fmet-tRNAF was isolated by the procedure of DUBNOFF and MAITRA". [3H] finet-tRNA,, was prepared as described by CASKEY et al. 7 and had a specific activity of approximately 900 epm/pmole. Initiation factors were isolated from the first ribosomal salt wash fluid".
The trinucleotide A-U-G was obtained from Collaborative Research, Inc., Waltham,
Mass.
Binding of fmet-tRNA,., to 70S ribosomes and 30S ribosomal subunits was assessed by the nitrocellulose filtration technique.
The reaction mixtures contained in a total volume of 0. The enzymatic formation of 30S initiation complexes which functionally preceeds the formation of the 70S complex was also subject to spectinomycin inhibition (Fig. 3) . Unexpectedly, nonenzymatic initiation complex formation was also inhibited by spectinomycin (Fig. 3 ). As shown above the corresponding 70S initiation complex formation process was stimulated by spectinomycin.
We thus formed non-enzymatic initiation complexes in the presence or absence of spectinomycin and then added 50S subunits to such reaction mixtures. The 50S preparation contained only trace amounts of 30S subunits as evidenced by electrophoresis on composite polyacrylamide-agarose gels prepared as described by HERMoso and SZER.9t Addition of 50S subunits to the 30S initiation complex resulted in a drastic increase of the amount of fmet-tRNAF bound in both the control samples and the ones containing spectinomycin (Fig. 4) . As only one molecule of fmet-tRNAF will bind per 30S subunit this suggests that in our control mixtures a portion of the 30S subunits was unable to combine efficiently with A-U-G and fmet-tRNAF but was rendered reactive after the addition of 50S subunits. The 50S subunits may thus exert some catalytic effect upon the 30S subunit in such a manner that the latter one can now participate in the initiation process. Spectinomycin did inhibit the formation of 30S initiation complexes in the absence of 50S subunits as expected but following the addition of 50S subunits inhibition was reversed and minor stimulation of fmet-tRNAF binding was observed.
Hence spectinomycin apparently suppresses the formation of Mg-+ induced 30S initiation complexes but this inhibition is completely reversed upon addition of 50S subunits.
Enzymatic 30S initiation complexes were also formed, followed by the addition of 50S subunits.
In this case spectinomycin-induced inhibition persisted after the addition of 50S subunits and was thus not reversed by 50S subunits as observed with the corresponding Mgt+-induced system (Fig. 5) . Furthermore, it was apparent that the addition of 50S subunits to 30S complexes in the control samples did not significantly enhance the extent of fmet-tRNAF binding as we had observed in the Mgt+-induced system.
If the enzymatic 30S initiation complex was preformed and then exposed to spectinomycin, dissociation of the complex occurred (Fig. 6) . Similarly, preformed Mgt+-induced 30S initiation complexes underwent dissociation after exposure to spectinomycin (Fig. 6 ). Hence enzymatic as well as nonenzymatic preformed 30S initiation complexes are rendered unstable by spectinomycin.
Initiation Complexes Formed with R17 Phage RNA Spectinomycin was found to inhibit the enzymatic as well as the non-enzymatic formation of 70S complexes consisting of R1; phage RNA, finet-tRNAF and salt-washed 70S ribosomes (Fig. 7) . It was somewhat surprising to find that non-enzymatic initiation in the phage-induced system was also subject to spectinomycin inhibition as we had found previously that this process is stimulated by the antibiotic if the initiator triplet A-U-G was used.
Spectinomycin was also found to inhibit both the enzymatic and non-enzymatic assembly of 30S initiation complexes induced with phage RNA (Fig. 8) . The formation of the 30S complex preceeds the formation of the 70S complex. It thus follows that spectinomycin inhibits initiation by interacting with an event or events occurring during the formation of the 30S complex.
Preformed enzymatic as well as Mg'-+-induced 30S initiation complexes started to dissociate immediately after the addition of spectinomycin (Fig. 9) . The antibiotic thus also renders phage RNA induced complexes unstable.
Discussion
The results presented show that spectinomycin inhibits the formation of both enzymatically and Mgt+-induced 30S initiation complexes formed with A-U-G, fmet-tRNAF and 30S ribosomal subunits. The antibiotic also induces dissociation of preformed 30S initiation complexes regardless whether they are formed enzymatically or non-enzymatically which indicates that such complexes are rendered unstable upon exposure to spectinomycin. On the other hand, only the enzymatic formation or stability of 70S initiation complexes is impaired by spectinomycin. The non-enzymatic initiation process is actually stimulated by spectinomycin. Addition of 50S subunits to Mgs+-induced 30S initiation complexes reverses the inhibitory activity of spectinomycin on the formation of the 30S complex. Spectinomycin also inhibits the enzymatic and non-enzymatic initiation processes studied in 30S and 70S phage RNA induced systems. As the 30S complex formation preceeds the 70S complex formation, it follows that spectinomycin interacts with one or several initiation functions associated with the assembly of the 30S complex. This conclusion is further substantiated by the observation that preformed 30S complexes are rendered unstable when exposed to the antibiotic. This transition from large polysomes to oligo and particularly to monosomes in whole cells is compatible with our observation that spectinomycin inhibits the initiation process as already initiated ribosomes engaged in peptide chain elongation will continue to synthesize protein in the presence of spectinomycin until they reach the end of the translational message. At this point they will release from the mRNA and as they are unable to reinitiate, they will accumulate as monosomes.
Within the time span the reactions were run, initiation in these specific cell-free systems was never completely suppressed by the antibiotic, even in the presence of high antibiotic concentrations. The inhibition kinetics also show that the inhibitory action of spectinomycin exerted on the initiation processes studied is slow as significant inhibition takes effect only several minutes after the start of the reaction. However, this slow rate of expression does not argue against the conclusion that spectinomycin inhibits protein synthesis by virtue of inhibiting chain initiation as the final effect (meaning cessation of protein synthesis) is the same regardless of the slow kinetics.
